UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$246.1K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 16, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$498.48
Sep 16, 2026
Close before public filing
$498.48
Sep 16, 2026
Return since public filing
-0.77%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 492 shares @ $500.19
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000143
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$5.88M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 16, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $1.04M |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $608.97K |
| United Therapeutics Corp UTHR Current | Sale | Sep 16, 2026 | $246.1K |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $355.08K |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $1.09M |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $774.43K |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $595.93K |
| United Therapeutics Corp UTHR | Sale | Sep 16, 2026 | $60.62K |
| United Therapeutics Corp UTHR | Exercise | Sep 16, 2026 | $0 |